GlassScriptPhysician profile
Mian A Yousuf
NPI 1841491297
$4,705.41
in general payments reported to CMS, 2019-2025
33 companies · $797 in 2025
The $797 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2020: $233 · 2021: $620 · 2022: $895 · 2023: $1,263 · 2024: $616 · 2025: $797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,675.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $558.44 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $510.75 | 2021-2025 | Verquvo |
| Inari Medical, INC. | $403.34 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $367.76 | 2019-2025 | Jot Dx, Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| E.R. Squibb & Sons, L.L.C. | $365.54 | 2020-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $347.02 | 2022-2025 | Jardiance |
| Livanova USA, INC. | $311.08 | 2023 | Lifesparc |
| Pfizer INC. | $278.32 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $255.50 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $146.89 | 2020-2023 | Farxiga, Brilinta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $124.95 | 2021-2025 | Lifevest |
| Abiomed | $121.54 | 2020-2025 | |
| Amgen INC. | $119.24 | 2020-2023 | Repatha |
| Companion Medical, INC. | $108.92 | 2019 | |
| Scpharmaceuticals INC. | $89.16 | 2023-2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $82.52 | 2022-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Cvrx, INC. | $79.29 | 2024-2025 | Barostim Neo System |
| Medtronic Vascular, INC. | $50.57 | 2019 | |
| Vital Connect, INC | $47.11 | 2025 | Vitalpatch Rtm |
| Lexicon Pharmaceuticals, INC. | $45.76 | 2023-2024 | Inpefa |
| Vifor Pharma, INC. | $39.98 | 2021 | |
| Ge Healthcare | $35.16 | 2024 | |
| Stryker Corporation | $34.24 | 2025 | Flowtriever |
| Esperion Therapeutics, INC. | $32.79 | 2020-2023 | Nexletol |
| Amarin Pharma, INC. | $24.14 | 2019 | |
| Terumo Medical Corporation | $18.55 | 2024 | Angio-Seal |
| Medtronic, INC. | $18.05 | 2021 | |
| Sanofi-Aventis U.S. LLC | $17.91 | 2022 | |
| Teleflex LLC | $17.50 | 2025 | Trapliner |
| G Medical Diagnostic Services, INC. | $14.58 | 2022 | |
| Angiodynamics, INC. | $14.45 | 2022 | |
| Boston Scientific Corporation | $12.89 | 2023 | Angiojet Ultra 5000a |
| Irhythm Technologies, INC. | $11.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mian Yousuf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.